Global hERG Screening Market 2022-2028

August 2022 | 73 pages | ID: GD3A98C2B404EN
Gen Consulting Company

Abstracts

The global herg screening market was valued at USD 1,633 million in 2021 to USD 3,043 million by 2028, progressing at a CAGR of 9.3% from 2022 to 2028, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global herg screening market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the herg screening industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, ion channel, application, and region. The global market for herg screening can be segmented by type: gene KCNH2, mutant KCNH2. Herg screening market is further segmented by ion channel: ligand-gated ion channels, voltage-gated ion channels, others. Based on application, the herg screening market is segmented into: antiarrhythmic, antibiotics, antipsychotics, others. On the basis of region, the herg screening market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:

• gene KCNH2
• mutant KCNH2

By ion channel:

• ligand-gated ion channels
• voltage-gated ion channels
• others

By application:

• antiarrhythmic
• antibiotics
• antipsychotics
• others

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The report explores the recent developments and profiles of key vendors in the Global hERG Screening Market, including Abcam PLC, Aurora Biomed Inc., B'SYS GmbH, Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, Merck KGaA, Metrion Biosciences Ltd., Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global herg screening market.
• To classify and forecast the global herg screening market based on type, ion channel, application, region.
• To identify drivers and challenges for the global herg screening market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global herg screening market.
• To identify and analyze the profile of leading players operating in the global herg screening market.

Why Choose This Report

• Gain a reliable outlook of the global herg screening market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE

Gene KCNH2
Mutant KCNH2

PART 6. MARKET BREAKDOWN BY ION CHANNEL

Ligand-gated ion channels
Voltage-gated ion channels
Others

PART 7. MARKET BREAKDOWN BY APPLICATION

Antiarrhythmic
Antibiotics
Antipsychotics
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 9. KEY COMPANIES

Abcam PLC
Aurora Biomed Inc.
B'SYS GmbH
Charles River Laboratories International, Inc.
Creative Bioarray
Eurofins Scientific SE
Merck KGaA
Metrion Biosciences Ltd.
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER